Cizkova M - Search Results

1

Gene expression profiling reveals new aspects of PIK3CA mutation in ERalpha-positive breast cancer: major implication of the Wnt signaling pathway.

Cizkova M, Cizeron-Clairac G, Vacher S, Susini A, Andrieu C, Lidereau R, Bièche I. Cizkova M, et al. PLoS One. 2010 Dec 30;5(12):e15647. doi: 10.1371/journal.pone.0015647. PLoS One. 2010. PMID: 21209903 Free PMC article.

2

PIK3CA mutation impact on survival in breast cancer patients and in ERα, PR and ERBB2-based subgroups.

Cizkova M, Susini A, Vacher S, Cizeron-Clairac G, Andrieu C, Driouch K, Fourme E, Lidereau R, Bièche I. Cizkova M, et al. Breast Cancer Res. 2012 Feb 13;14(1):R28. doi: 10.1186/bcr3113. Breast Cancer Res. 2012. PMID: 22330809 Free PMC article.

3

PIK3R1 underexpression is an independent prognostic marker in breast cancer.

Cizkova M, Vacher S, Meseure D, Trassard M, Susini A, Mlcuchova D, Callens C, Rouleau E, Spyratos F, Lidereau R, Bièche I. Cizkova M, et al. BMC Cancer. 2013 Nov 14;13:545. doi: 10.1186/1471-2407-13-545. BMC Cancer. 2013. PMID: 24229379 Free PMC article.

4

Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with trastuzumab.

Cizkova M, Dujaric ME, Lehmann-Che J, Scott V, Tembo O, Asselain B, Pierga JY, Marty M, de Cremoux P, Spyratos F, Bieche I. Cizkova M, et al. Br J Cancer. 2013 May 14;108(9):1807-9. doi: 10.1038/bjc.2013.164. Epub 2013 Apr 23. Br J Cancer. 2013. PMID: 23612454 Free PMC article.

5

Lapatinib in breast cancer - the predictive significance of HER1 (EGFR), HER2, PTEN and PIK3CA genes and lapatinib plasma level assessment.

Bouchalova K, Cizkova M, Cwiertka K, Trojanec R, Friedecky D, Hajduch M. Bouchalova K, et al. Among authors: cizkova m. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2010 Dec;154(4):281-8. doi: 10.5507/bp.2010.043. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2010. PMID: 21293538 Free article. Review.

6

High lapatinib plasma levels in breast cancer patients: risk or benefit?

Cizkova M, Bouchalova K, Friedecky D, Polynkova A, Janostakova A, Radova L, Cwiertka K, Trojanec R, Zezulova M, Zlevorova M, Hajduch M, Melichar B. Cizkova M, et al. Tumori. 2012 Jan-Feb;98(1):162-5. doi: 10.1177/030089161209800123. Tumori. 2012. PMID: 22495718

7

Triple negative breast cancer--current status and prospective targeted treatment based on HER1 (EGFR), TOP2A and C-MYC gene assessment.

Bouchalova K, Cizkova M, Cwiertka K, Trojanec R, Hajduch M. Bouchalova K, et al. Among authors: cizkova m. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009 Mar;153(1):13-7. doi: 10.5507/bp.2009.002. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009. PMID: 19365520 Review.

8

Collagen triple helix repeat containing 1 protein, periostin and versican in primary and metastatic breast cancer: an immunohistochemical study.

Kharaishvili G, Cizkova M, Bouchalova K, Mgebrishvili G, Kolar Z, Bouchal J. Kharaishvili G, et al. Among authors: cizkova m. J Clin Pathol. 2011 Nov;64(11):977-82. doi: 10.1136/jclinpath-2011-200106. Epub 2011 Jul 8. J Clin Pathol. 2011. PMID: 21742751

9

Distribution of nickel in body fluids and organs of rats chronically exposed to nickel sulphate.

Severa J, Vyskocil A, Fiala Z, Cizkova M. Severa J, et al. Among authors: cizkova m. Hum Exp Toxicol. 1995 Dec;14(12):955-8. doi: 10.1177/096032719501401204. Hum Exp Toxicol. 1995. PMID: 8962746

10

Chronic nephrotoxicity of soluble nickel in rats.

Vyskocil A, Viau C, Cízková M. Vyskocil A, et al. Among authors: cizkova m. Hum Exp Toxicol. 1994 Oct;13(10):689-93. doi: 10.1177/096032719401301007. Hum Exp Toxicol. 1994. PMID: 7826687

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters